Citations

Clear

585 citation(s) found for "Tran, Ha".

Electromyographic Evaluation of a Bed Assistive Device for Abdominal Surgery Patients in Postoperative Care
Tran, Grace, Babski-Reeves, Kari , Nussbaum, Maury A.

Mayo Clinic

Human Factors: The Journal of the Human Factors and Ergonomics Society | April 16, 2008 | Volume: 50 | Issue: 2 | Pages: 237-255

10.1518/001872008x250764 | PMID 18516835 Get It

Objective: Muscle activity with and without the use of commercially available patient assistive devices during bed rising and lowering was quantified. Background: Limited research is available in understanding or evaluating the physical benefits of assistive devices for patient use following major abdominal surgery. Methods: Twenty healthy participants (9 men, 11 women) took part in a laboratory study to test the effects of device configuration (five levels) and bed elevation angle (0° and 30°) on mean and peak upper and lower rectus abdominis and external oblique concentric and eccentric muscle activity. Results: Reduced muscle activity was associated with the use of an assistive device, as compared with manual bed rising (unassisted). Positioning the devices at a higher anchor height and/or increasing the bed elevation angle further reduced muscle activity. Objective and subjective differences between the two assistive devices evaluated in the study were found. Conclusion: These results suggest that self-assistive devices may speed recovery because of reduced loads on damaged tissues. Application: Potential applications of this research include the assessment of other commercially available lift aids or comparisons of self-assistive lift aids with hospital-housed lift aids used to speed recovery rates.
Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome
Tran, Nhan L. , McDonough, Wendy S., Savitch, Benjamin A., Ensign, Shannon P. Fortin , Winkles, Jeffrey A. , Symons, Marc , Cunliffe, Heather E. , Hoelzinger, Dominique B. , Rennert, Jessica L., Burkly, Linda C. , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Nakada, Mitsutoshi , Hostetter, Galen H. , Michaelson, Jennifer S. , Lipinski, Christopher A. , Mariani, Luigi , Berens, Michael E. , Tran, Nhan L

Mayo Clinic

Cancer Research | October 3, 2006 | Volume: 66 | Issue: 19 | Pages: 9535-9542

10.1158/0008-5472.can-06-0418 | PMID 17018610 Get It

Abstract Glial tumors progress to malignant grades by heightened proliferation and relentless dispersion throughout the central nervous system. Understanding genetic and biochemical processes that foster these behaviors is likely to reveal specific and effective targets for therapeutic intervention. Our current report shows that the fibroblast growth factor-inducible 14 (Fn14), a member of the tumor necrosis factor (TNF) receptor superfamily, is expressed at high levels in migrating glioma cells in vitro and invading glioma cells in vivo. Forced Fn14 overexpression stimulates glioma cell migration and invasion, and depletion of Rac1 by small interfering RNA inhibits this cellular response. Activation of Fn14 signaling by the ligand TNF-like weak inducer of apoptosis (TWEAK) stimulates migration and up-regulates expression of Fn14; this TWEAK effect requires Rac1 and nuclear factor-κB (NF-κB) activity. The Fn14 promoter region contains NF-κB binding sites, which mediate positive feedback causing sustained overexpression of Fn14 and enduring glioma cell invasion. Furthermore, Fn14 gene expression levels increase with glioma grade and inversely correlate with patient survival. These results show that the Fn14 cascade operates as a positive feedback mechanism for elevated and sustained Fn14 expression. Such a feedback loop argues for aggressive targeting of the Fn14 axis as a unique and specific driver of glioma malignant behavior. (Cancer Res 2006; 66(19): 9535-42)
Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance
Frost, Marlene H., Slezak, Jeffrey M., Tran, Nho V. , Williams, Constance I., Johnson, Joanne L., Woods, John E., Petty, Paul M., Donohue, John H., Grant, Clive S., Sloan, Jeff A. , Sellers, Thomas A. , Hartmann, Lynn C.

Mayo Clinic

Journal of Clinical Oncology | October 4, 2005 | Volume: 23 | Issue: 31 | Pages: 7849-7856

10.1200/jco.2005.09.233 | PMID 16204003 Get It

Purpose Contralateral prophylactic mastectomy (CPM) is one option for reducing the risk of a second breast cancer in women with a personal and family history of breast cancer. Few data are available regarding satisfaction, psychological, and social function after CPM. The purpose of this research is to evaluate women’s long-term satisfaction with CPM, factors influencing satisfaction, and psychological and social function after CPM. Patients and Methods This was a descriptive study of all women with a family history of breast cancer, known to be alive, who elected CPM at Mayo Clinic (Rochester, MN) between 1960 and 1993 (n = 621). Ninety-four percent of the women (n = 583) completed a study-specific questionnaire. Results A mean of 10.3 years after the procedure, the majority of women (83%) were satisfied with their CPM. A smaller number were neutral (8%) or dissatisfied (9%). Women who had a subcutaneous mastectomy had more problems with reconstruction, and fewer of these women were satisfied than women with simple mastectomy. Decreased satisfaction with CPM was associated with decreased satisfaction with appearance, complications with reconstruction, reconstruction after CPM, and increased level of stress in life. The majority of women experienced no change or favorable effects in self-esteem (83%), level of stress in life (83%), and emotional stability (88%). Satisfaction with body appearance, feelings of femininity, and sexual relationships were the most adversely affected with 33%, 26%, and 23% of the women responding negatively. Conclusion Although most women are satisfied with CPM, each woman should weigh the benefits alongside the potential adverse effects.
URINARY FISTULAS FOLLOWING EXTERNAL RADIATION OR PERMANENT BRACHYTHERAPY FOR THE TREATMENT OF PROSTATE CANCER
Chrouser, Kristin , Leibovich, Bradley C. , SWEAT, SUSAN D., Davis, Brian J. , Tran, Nho V. , Zincke, Horst, Blute, Michael L., Larson, David W. , Davis, Brian J

Mayo Clinic

Journal of Urology | May 3, 2005 | Volume: 173 | Issue: 6 | Pages: 1953-1957

10.1097/01.ju.0000158041.77063.ff | PMID 15879789 Get It